Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Jaguar Health (JAGX) Receivables - Other (2016 - 2025)

Jaguar Health (JAGX) has disclosed Receivables - Other for 11 consecutive years, with $67000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Other rose 17.54% to $67000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $67000.0, a 17.54% increase, with the full-year FY2024 number at $120000.0, down 44.7% from a year prior.
  • Receivables - Other was $67000.0 for Q3 2025 at Jaguar Health, down from $143000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $634000.0 in Q3 2022 to a low of $30000.0 in Q1 2021.
  • A 5-year average of $243842.1 and a median of $166000.0 in 2025 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: skyrocketed 3033.33% in 2021, then plummeted 73.03% in 2023.
  • Jaguar Health's Receivables - Other stood at $435000.0 in 2021, then surged by 35.17% to $588000.0 in 2022, then plummeted by 63.1% to $217000.0 in 2023, then crashed by 44.7% to $120000.0 in 2024, then plummeted by 44.17% to $67000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Receivables - Other are $67000.0 (Q3 2025), $143000.0 (Q2 2025), and $166000.0 (Q1 2025).